Researchers identify new choice of therapy for rare autoimmune disease EGPA
An international team has identified a new therapeutic for patients with a rare autoimmune disease called eosinophilic granulomatosis with polyangiitis (EGPA). A biologic drug called benralizumab has been shown to be non-inferior ...
Feb 23, 2024
0
1